arrow
G

Gwangil Kim

pochon cha university
H指数:24
被引数:2,080

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrative multi-omics profiling identifies infiltrative hepatocellular carcinoma as an immunotherapy-resistant subtype with distinct molecular features

Lee, W.S.; Woo, S.; Lee, S.H.; Jo, G.H.; Kim, I.; Kim, H.; An, C.; Jung, S.; Kim, G.; Kang, H.; et al. 多组学整合分析鉴定出浸润性HCC为具有独特分子特征且对免疫治疗抵抗的亚型。韩国肝病杂志. 2025; 已接收. [Google Scholar] [CrossRef]

2026-01-011
OA
Differential implications of tumor endothelial cell and lymphocyte densities in advanced hepatocellular carcinoma patients treated with immunotherapy

肿瘤内皮细胞和淋巴细胞密度在免疫治疗治疗的晚期肝细胞癌患者中的差异意义

2025-12-110
OAAI
Biology-driven stratification of advanced biliary tract cancer treated with nab-paclitaxel plus gemcitabine-cisplatin: A prospective observational cohort study

基于生物学的晚期胆道癌nab-紫杉醇联合吉西他滨-顺铂治疗方案分层:一项前瞻性观察性队列研究

2025-12-010
PRE
Pathologist-Artificial Intelligence (AI) Concordance in HER2 Interpretation for Advanced Biliary Tract Cancer: Intra-observer, Inter-observer, and Human-AI Variability

病理学家-人工智能(AI)在HER2解读中的符合度比较:对晚期胆道癌的内部观察者、外部观察者及人机变异分析

2025-11-120
PRE
Clinical Feasibility of Circulating Tumor DNA in Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab

晚期肝细胞癌患者接受阿替利珠单抗联合贝伐珠单抗治疗时循环肿瘤DNA的临床可行性

2025-11-010
OA